ADAM10 is involved in the oncogenic process and chemo-resistance of triple-negative breast cancer via regulating Notch1 signaling pathway, CD44 and PrPc.
Saved in:
| Title: | ADAM10 is involved in the oncogenic process and chemo-resistance of triple-negative breast cancer via regulating Notch1 signaling pathway, CD44 and PrPc. |
|---|---|
| Authors: | Cheng, Yuanyuan1 (AUTHOR) chengwang0915@163.com, Lin, Lishuang1 (AUTHOR), Li, Xiaoyan2 (AUTHOR), Lu, Aiqi1 (AUTHOR), Hou, Chenjian3 (AUTHOR), Wu, Qian1 (AUTHOR), Hu, Xiaomu1 (AUTHOR), Zhou, Zhongwen1 (AUTHOR), Chen, Zhongqing1 (AUTHOR), Tang, Feng1 (AUTHOR) |
| Source: | Cancer Cell International. 1/7/2021, Vol. 21 Issue 1, p1-15. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 147996679 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: ADAM10 is involved in the oncogenic process and chemo-resistance of triple-negative breast cancer via regulating Notch1 signaling pathway, CD44 and PrPc. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Cheng%2C+Yuanyuan%22">Cheng, Yuanyuan</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> chengwang0915@163.com</i><br /><searchLink fieldCode="AR" term="%22Lin%2C+Lishuang%22">Lin, Lishuang</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Xiaoyan%22">Li, Xiaoyan</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lu%2C+Aiqi%22">Lu, Aiqi</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hou%2C+Chenjian%22">Hou, Chenjian</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wu%2C+Qian%22">Wu, Qian</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hu%2C+Xiaomu%22">Hu, Xiaomu</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhou%2C+Zhongwen%22">Zhou, Zhongwen</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+Zhongqing%22">Chen, Zhongqing</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tang%2C+Feng%22">Tang, Feng</searchLink><relatesTo>1</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Cancer+Cell+International%22">Cancer Cell International</searchLink>. 1/7/2021, Vol. 21 Issue 1, p1-15. 15p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=147996679 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12935-020-01727-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 15 StartPage: 1 Titles: – TitleFull: ADAM10 is involved in the oncogenic process and chemo-resistance of triple-negative breast cancer via regulating Notch1 signaling pathway, CD44 and PrPc. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Cheng, Yuanyuan – PersonEntity: Name: NameFull: Lin, Lishuang – PersonEntity: Name: NameFull: Li, Xiaoyan – PersonEntity: Name: NameFull: Lu, Aiqi – PersonEntity: Name: NameFull: Hou, Chenjian – PersonEntity: Name: NameFull: Wu, Qian – PersonEntity: Name: NameFull: Hu, Xiaomu – PersonEntity: Name: NameFull: Zhou, Zhongwen – PersonEntity: Name: NameFull: Chen, Zhongqing – PersonEntity: Name: NameFull: Tang, Feng IsPartOfRelationships: – BibEntity: Dates: – D: 07 M: 01 Text: 1/7/2021 Type: published Y: 2021 Identifiers: – Type: issn-print Value: 14752867 Numbering: – Type: volume Value: 21 – Type: issue Value: 1 Titles: – TitleFull: Cancer Cell International Type: main |
| ResultId | 1 |
